CPHCipher Pharmaceuticals Inc.
16.88CADMkt Cap: 428.61M CADP/E: 10.36Last update: 2026-05-21

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and r…

loading…
Indicators:|

Key Statistics

Company
Market Cap428.61M CAD
Enterprise Value427.48M CAD
Revenue (TTM)50.94M CAD
Gross Profit40.42M CAD
Net Income (TTM)27.33M CAD
Revenue/Share2.010 CAD
Last Price16.88 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN
Valuation
P/E (Trailing)10.36
P/E (Forward)14.81
PEG
EV/EBITDA15.81
EV/Revenue8.39
P/S8.41
P/B2.38
EPS (TTM)1.64
EPS (Forward)1.14
52W Range
16.7240% of range17.12
52W High17.12 CAD
52W Low16.72 CAD
Profitability
Gross Margin80.12%
Oper. Margin44.74%
EBITDA Margin53.10%
Profit Margin54.17%
ROE21.65%
ROA17.46%
Growth
Revenue Growth4.00%
Earnings Growth140.00%
Cash Flow & Leverage
Operating CF29.73M CAD
CapEx (TTM)201.00K CAD
FCF Margin43.76%
FCF Yield5.20%
Net Debt-5.98M CAD
Net Debt/EBITDA-0.22
Balance Sheet
Debt/Equity0.04
Current Ratio1.25
Quick Ratio0.79
Book Value/Sh7.107 CAD
Cash/Share0.2500 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)20.64 CAD
Target Range17.00 CAD22.25 CAD
# Analysts4
Ownership
Shares Out.25.39M
Float15.09M
Insiders42.39%
Institutions1.31%
Short Interest
Short Ratio1.9d
Short % Out.0.23%
Shares Short69.66K
Short (prev mo.)64.79K
Technical
SMA 5017.77 (-5.0%)
SMA 20015.61 (+8.2%)
Beta
S&P 52W Chg28.31%
Avg Vol (30d)18.61K
Avg Vol (10d)46.86K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)